WinstonWınston
Back
Medcann Industries logo

Medcann Industries

NSRS
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$35,902
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count falling — buybacks

100.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 344K (2017) → 159.016 (2021)

Winston Score History

The full picture

North Springs Resources Corp is a small healthcare company operating in the specialty and generic drug manufacturing industry. It focuses on developing and bringing pharmaceutical products to market, targeting patients and healthcare providers who need affordable or specialized medications. The company sits in a sector where firms either create new drugs or produce lower-cost copies of existing ones.

The company generates revenue through drug sales, licensing agreements, or partnerships, which is typical for businesses at this stage in the pharmaceutical space. It appears to be a very early-stage or micro-cap operation, given its near-zero market cap and margins, suggesting it has little to no commercial revenue at this time. The primary risk is that small drug companies frequently run out of cash before reaching profitability, and without approved products generating steady sales, the business depends heavily on outside funding to survive and grow.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-102.2% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

Research and development spending

Insider Activity

79.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$16 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Medcann Industries has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
-4.2%
Weak — -4.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
-109.0%
Earnings shrinking (-109.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
2.20
Heavy debt load (2.20)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial